148 related articles for article (PubMed ID: 25451900)
1. Decreased A20 mRNA and protein expression in peripheral blood mononuclear cells in patients with type 2 diabetes and latent autoimmune diabetes in adults.
Cheng L; Zhang D; Jiang Y; Deng W; Wu Q; Jiang X; Chen B
Diabetes Res Clin Pract; 2014 Dec; 106(3):611-6. PubMed ID: 25451900
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
3. Aberrant Low Expression of A20 in Tumor Necrosis Factor-α-stimulated SLE Monocytes Mediates Sustained NF-κB Inflammatory Response.
Shi X; Qian T; Li M; Chen F; Chen Y; Hao F
Immunol Invest; 2015; 44(5):497-508. PubMed ID: 26107748
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of A20 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Li D; Wang L; Fan Y; Song L; Guo C; Zhu F; Zhang L; Shi Y
J Clin Immunol; 2012 Dec; 32(6):1287-91. PubMed ID: 22898832
[TBL] [Abstract][Full Text] [Related]
5. Increased A20 mRNA Level in Peripheral Blood Mononuclear Cells is Associated With Immune Phases of Patients With Chronic Hepatitis B.
Sun YY; Fan YC; Wang N; Xia HH; Xiao XY; Wang K
Medicine (Baltimore); 2015 Dec; 94(52):e2428. PubMed ID: 26717404
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis.
Zhu L; Wang L; Wang X; Zhou L; Liao Z; Xu L; Wu H; Ren J; Li Z; Yang L; Chen S; Li B; Wu X; Zhou Y; Li Y
J Transl Med; 2015 Jul; 13():215. PubMed ID: 26143186
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of A20 gene expression in peripheral blood mononuclear cells is associated with acute-on-chronic hepatitis B liver failure.
Fan YC; Sun YY; Wang N; Xiao XY; Wang K
J Viral Hepat; 2016 Mar; 23(3):180-90. PubMed ID: 26400407
[TBL] [Abstract][Full Text] [Related]
8. Tag polymorphisms at the A20 (TNFAIP3) locus are associated with lower gene expression and increased risk of coronary artery disease in type 2 diabetes.
Boonyasrisawat W; Eberle D; Bacci S; Zhang YY; Nolan D; Gervino EV; Johnstone MT; Trischitta V; Shoelson SE; Doria A
Diabetes; 2007 Feb; 56(2):499-505. PubMed ID: 17259397
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor alpha-induced protein 3 mRNA in peripheral blood mononuclear cells negatively correlates with disease severity in psoriasis vulgaris.
Jiang X; Tian H; Fan Y; Chen J; Song Y; Wang S; Zhu F; Guo C; Zhang L; Shi Y
Clin Vaccine Immunol; 2012 Dec; 19(12):1938-42. PubMed ID: 23054742
[TBL] [Abstract][Full Text] [Related]
10. Intron-derived aberrant splicing of A20 transcript in rheumatoid arthritis.
Yoon HK; Byun HS; Lee H; Jeon J; Lee Y; Li Y; Jin EH; Kim J; Hong JH; Kim JH; Seok JH; Kang SW; Lee WH; Hur GM
Rheumatology (Oxford); 2013 Mar; 52(3):427-37. PubMed ID: 23148088
[TBL] [Abstract][Full Text] [Related]
11. TLR2 and TLR4 expression on CD14(++) and CD14(+) monocyte subtypes in adult-onset autoimmune diabetes.
Cejkova P; Nemeckova I; Broz J; Cerna M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):76-83. PubMed ID: 25942429
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
Vereecke L; Beyaert R; van Loo G
Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
[TBL] [Abstract][Full Text] [Related]
13. microRNA-143-3p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus.
Pan S; Li M; Yu H; Xie Z; Li X; Duan X; Huang G; Zhou Z
Acta Diabetol; 2021 Jan; 58(1):63-72. PubMed ID: 32815005
[TBL] [Abstract][Full Text] [Related]
14. Expression of the inflammatory regulator A20 correlates with lung function in patients with cystic fibrosis.
Kelly C; Williams MT; Elborn JS; Ennis M; Schock BC
J Cyst Fibros; 2013 Jul; 12(4):411-5. PubMed ID: 23164641
[TBL] [Abstract][Full Text] [Related]
15. Downstream activation of NF-κB in the EDA-A1/EDAR signalling in Sjögren's syndrome and its regulation by the ubiquitin-editing enzyme A20.
Sisto M; Barca A; Lofrumento DD; Lisi S
Clin Exp Immunol; 2016 May; 184(2):183-96. PubMed ID: 26724675
[TBL] [Abstract][Full Text] [Related]
16. Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.
Wang X; Zhu L; Liao Z; Zhang F; Xu L; Xu Y; Chen S; Yang L; Zhou Y; Li Y
J Immunol Res; 2014; 2014():492872. PubMed ID: 24971370
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of A20 gene in peripheral blood mononuclear cells is associated with the progression of chronic hepatitis B virus infection.
Fan YC; Zhang YY; Sun YY; Wang N; Xiao XY; Wang K
Oncotarget; 2016 Oct; 7(42):68821-68832. PubMed ID: 27634895
[TBL] [Abstract][Full Text] [Related]
18. Frequent down regulation of the tumor suppressor gene a20 in multiple myeloma.
Troppan K; Hofer S; Wenzl K; Lassnig M; Pursche B; Steinbauer E; Wiltgen M; Zulus B; Renner W; Beham-Schmid C; Deutsch A; Neumeister P
PLoS One; 2015; 10(4):e0123922. PubMed ID: 25856582
[TBL] [Abstract][Full Text] [Related]
19. A20 overexpression under control of mouse osteocalcin promoter in MC3T3-E1 cells inhibited tumor necrosis factor-alpha-induced apoptosis.
Qin YJ; Zhang ZL; Yu LY; He JW; Hou YN; Liu TJ; Wu JC; Wu SH; Guo LH
Acta Pharmacol Sin; 2006 Sep; 27(9):1231-7. PubMed ID: 16923345
[TBL] [Abstract][Full Text] [Related]
20. A20 inhibits human salivary adenoid cystic carcinoma cells invasion via blocking nuclear factor-kappaB activation.
Zhang B; Guan CC; Chen WT; Zhang P; Yan M; Shi JH; Qin CL; Yang Q
Chin Med J (Engl); 2007 Oct; 120(20):1830-5. PubMed ID: 18028781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
